D Amp M Pharma Peru Sac -

DIGEMID - General Directorate of Medicines, Supplies and Drugs

In a context of economic contraction and disinvestment in certain sectors, D&M Pharma has adopted a counter-cyclical strategy focused on growth and job creation. In December 2023, the company announced an ambitious expansion plan: it was preparing and training new sales representatives, adding positions, and creating employment in its Cassará Division.

Peru has one of the strictest pharmaceutical regulatory bodies in Latin America. For to operate legally, they must possess: d amp m pharma peru sac

Rather than running heavy local industrial chemical plants, the company operates primarily as a sophisticated distributor and regulatory hub. They manage foreign commerce operations, handling both bulk imports and specific trade shipments through Veritrade analytical customs records under the tax identifier . Specialized Medical Portfolio

Backed by reputable partners such as Laboratorio Cassará. DIGEMID - General Directorate of Medicines, Supplies and

, was elected as Vice President of the Medicines Sector Board for the COMSALUD Gremio de Salud of the Lima Chamber of Commerce. or information on how to contact their regulatory department D & M Pharma Peru S.A.C. Company Profile - EMIS 31-Oct-2024 —

(General Directorate of Medicines, Supplies, and Drugs), the national authority for medicines in Peru. Product Specializations For to operate legally, they must possess: Rather

D&M Pharma Peru SAC offers a wide range of pharmaceutical products and services, catering to various therapeutic areas, including: